SHC - NASDAQ
Sotera Health Company
$15.27
+0.17%Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
At a Glance
Live SnapshotSotera Health Company Management Team
Mr. Michael B. Petras Jr.
Chairman & Chief Executive Officer
Compensation
$2,385,199
Ms. Sally R. Turner
Chief Human Resources Officer
Mr. Robert G. Hauzie
Chief Information Officer
Ms. Kristin A. Gibbs
Chief Marketing Officer
Mr. Joseph A. Shrawder
President of Nelson Labs
Mr. Michael P. Rutz
President of Sterigenics
Compensation
$1,480,605
Mr. Jonathan M. Lyons
Senior Vice President & Chief Financial Officer
Compensation
$937,584
Ms. Danielle J. Menture
Senior Vice President of Global Environmental, Health & Safety and Sustainability
Mr. William O. Lehmann Jr., J.D., M.B.A.
Senior Vice President of Strategy & Corporate Development
Mr. Alexander Dimitrief J.D.
Senior Vice President, General Counsel & Secretary
Compensation
$889,611
Sotera Health Company Insider Positioning
During the last 12 months, insiders have sold $1.91B worth of SHC shares, with no buying activity reported.
3 Months
0
0.00
56.8M
864.67M
-864.7M
-$864.67M
3-6 Months
0
0.00
394.9K
6.50M
-6.5M
-$6.50M
6-9 Months
0
0.00
46.2M
734.08M
-734.1M
-$734.08M
9-12 Months
0
0.00
20.1M
304.29M
-304.3M
-$304.29M
Top Buyers
No buying activity
Top Sellers
Warburg Pincus & Co.
Director, 10 Percent Owner:
$1.14B
Gtcr Investment Xi Llc
Director, 10 Percent Owner:
$760.39M
Petras Michael B. Jr.
Director, Officer: Chairman & Ceo
$6.50M
Rutz Michael P
Officer: President Of Sterigenics
$2.07M
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $1.91B net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SEC Filings
SHC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 08, 2026 | May 21, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 10, 2025 | May 21, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 11, 2024 | May 23, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 13, 2023 | April 13, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 14, 2022 | May 26, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 15, 2021 | May 27, 2021 | 2021 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.